We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Genzyme Therapeutics

4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU
Telephone: +44 (0)1865 405 200
Fax: +44 (0)1865 774 172
WWW: http://www.genzyme.co.uk
Medical Information Direct Line: +44 (0)1865 405 283
Medical Information e-mail: ukmedinfo@genzyme.com
Customer Care direct line: +44 (0)1865 405 200
Medical Information Facsimile: +44 (0)1865 774 172
Patient Information Leaflet last updated on medicines.ie: 12/01/2018
PIL LEMTRADA 12 mg concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 12/01/2018 and displayed until Current
Reasons for adding or updating:
  • Improved presentation of PIL
Updated on 18/12/2017 and displayed until 12/01/2018
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 05/12/2017 and displayed until 18/12/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to other sources of information section
Updated on 28/06/2016 and displayed until 05/12/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/12/2014 and displayed until 28/06/2016
Reasons for adding or updating:
  • Addition of information on reporting a side effect.
Updated on 29/07/2014 and displayed until 04/12/2014
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Alemtuzumab